目的 研究骨质疏松对小鼠骨髓间充质干细胞(mBMSCs)增殖、分化的影响,为骨质疏松的治疗提供理论和实验支持。 方法 30只C57BL/6小鼠随机分为假手术组和手术组,假手术组只去除卵巢周围脂肪,手术组去除卵巢。手术后8周分别取小鼠股骨和胫骨,分离培养mBMSCs,观察其增殖、分化的变化。 结果 骨质疏松小鼠的mBMSCs的增殖、迁移能力下降。碱性磷酸酶染色结果显示骨质疏松小鼠的mBMSCs成骨分化能力下降。 结论 骨质疏松模型小鼠mBMSCs的增殖、迁移和分化能力下降。
Abstract
Objective To study the effect of osteoporosis on the proliferation and differentiation of mouse bone marrow mesenchymal stem cells (mBMSCs), and to provide theoretical and experimental support for the treatment of osteoporosis. Methods Thirty C57BL/6 mice were randomly divided into sham operation group and operation group. Sham operation group only removed the fat around the ovary, and operation group removed the ovary. mBMSCs were taken from the femur and tibia of mice and cultured 8 weeks after operation to observe the changes of proliferation and differentiation. Results The proliferation and migration ability of mBMSCs in osteoporosis mice were decreased. The results of alkaline phosphatase staining showed that mBMSCs had decreased osteogenic differentiation ability in osteoporosis mice. Conclusions The proliferation, migration, and differentiation ability of mBMSCs in osteoporotic mice were decreased.
关键词
骨质疏松 /
  /
  /
小鼠骨髓间充质干细胞(mBMSCs) /
  /
  /
增殖 /
  /
  /
迁移 /
  /
  /
分化
Key words
Osteoporotic /
  /
  /
Mouse bone marrow mesenchymal stem cells (mBMSCs) /
  /
  /
Proliferation /
Migrate /
  /
  /
  /
Differentiation
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Zhao D, Saiding Q, Li Y, et al. Bone Organoids: Recent Advances and Future Challenges[J].Adv Healthc Mater, 2024,13(5):e2302088. DOI:10.1002/adhm.202302088.
[2] Yang Y, Wu S, Qu R, et al. Mechanical sensor PDLIM5 promotes the osteogenesis of human adipose-derived stem cells through microfilament alterations[J]. Genes Dis, 2024,11(3):101023. DOI: 10.1016/j.gendis.2023.06.00.
[3] Srivastava M, Deal C. Osteoporosis in elderly: prevention and treatment[J]. Clin Geriatr Med, 2002,18(3):529-555. DOI: 10.1016/s0749-0690(02)00022-8.
[4] Carletti A, Gavaia P J, Cancela M L, et al. Metabolic bone disorders and the promise of marine osteoactive compounds[J]. Cell Mol Life Sci, 2023,81(1):11. DOI: 10.1007/s00018-023-05033-x.
[5] Chen L, Yu C, Xu W, et al. Dual-Targeted Nanodiscs Revealing the Cross-Talk between Osteogenic Differentiation of Mesenchymal Stem Cells and Macrophages[J]. ACS Nano, 2023,17(3):3153-3167. DOI: 10.1021/acsnano.2c12440.
[6] Kim DY, Ko SH. Common Regulators of Lipid Metabolism and Bone Marrow Adiposity in Postmenopausal Women[J]. Pharmaceuticals (Basel), 2023,16(2):322. DOI: 10.3390/ph16020322.
[7] Wada N, Gronthos S, Bartold PM. Immunomodulatory effects of stem cells[J]. Periodontol 2000, 2013,63(1):198-216. DOI: 10.1111/prd.12024.
[8] Chu DT, Phuong T, Tien N, et al. An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells[J]. Int J Mol Sci, 2020,21(3):708. DOI: 10.3390/ijms21030708
[9] Naji A, Eitoku M, Favier B, et al. Biological functions of mesenchymal stem cells and clinical implications[J]. Cell Mol Life Sci, 2019,76(17):3323-3348. DOI: 10.1007/s00018-019-03125-1.
[10]Wang J, Liu S, Shi J, et al. The Role of lncRNAs in Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells[J]. Curr Stem Cell Res Ther, 2020,15(3):243-249. DOI: 10.2174/1574888X15666191227113742.
[11]Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: An Update[J]. Cell Transplant, 2016,25(5):829-848. DOI: 10.3727/096368915X689622.
[12]Zhang L, Zheng YL, Wang R, et al. Exercise for osteoporosis: A literature review of pathology and mechanism[J]. Front Immunol, 2022,13:1005665. DOI: 10.3389/fimmu.2022.1005665.
[13]刘少斐, 许冰冰. 骨髓间充质干细胞的分离、培养、鉴定及其在关节软骨损伤修复中的相关应用[J]. 中国比较医学杂志, 2023,33(9):149-154.DOI: 10.3969/ j.issn.1671-7856. 2023. 09.017
[14]Han Y, Li X, Zhang Y, et al. Mesenchymal Stem Cells for Regenerative Medicine[J]. Cells, 2019,8(8). DOI:10.3390/cells8080886
[15]Johnston CB, Dagar M. Osteoporosis in Older Adults[J]. Med Clin North Am, 2020,104(5):873-884. DOI: 10.1016/j.mcna.2020.06.004.
[16]LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician's guide to prevention and treatment of osteoporosis[J]. Osteoporos Int, 2022,33(10):2049-2102. DOI: 10.1007/s00198-021-05900-y.
基金
国家重点研发计划(2022YFF1202600)